Mirae Asset Global ETFs Holdings
NKTR icon

Mirae Asset Global ETFs Holdings’s Nektar Therapeutics NKTR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,126
Closed -$72.7K – 3160
2025
Q1 		$72.7K Buy
7,126
+302
+4% +$3.95K ﹤0.01% 2753
2024
Q4 		$95.2K Buy
6,824
+294
+5% +$5.18K ﹤0.01% 2718
2024
Q3 		$127K Buy
+6,530
New +$124K ﹤0.01% 2588

Other funds holding NKTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NKTR Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 7,126 shares — an estimated $72.7K sold.

Mirae Asset Global ETFs Holdings first reported a position in NKTR in Q3 2024 and held it in 3 quarters. The position peaked at $127K in Q3 2024. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 7,126 Nektar Therapeutics shares in Q2 2025, an estimated $72.7K.
  • Mirae Asset Global ETFs Holdings first reported a position in Nektar Therapeutics in Q3 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's Nektar Therapeutics position peaked at $127K in Q3 2024.
  • 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.